Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2409656121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Maryam Kazerani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig Maximilian University Munich, Martinsried 82152, Germany. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Hematopoiesis, Hematopoietic Stem Cells, Enhancer Elements, Genetic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
The H3K9me3-specific histone methyltransferase SETDB1 is critical for proper regulation of developmental processes, but the underlying mechanisms are only partially understood. Here, we show that deletion of Setdb1 in mouse fetal liver hematopoietic stem and progenitor cells (HSPCs) results in compromised stem cell function, enhanced myeloerythroid differentiation, and impaired lymphoid development. Notably, Setdb1 -deficient HSPCs exhibit reduced quiescence and increased proliferation, accompanied by the acquisition of a lineage-biased transcriptional program. In Setdb1 -deficient HSPCs, we identify genomic regions that are characterized by loss of H3K9me3 and increased chromatin accessibility, suggesting enhanced transcription factor (TF) activity. Interestingly, hematopoietic TFs like PU.1 bind these cryptic enhancers in wild-type HSPCs, despite the H3K9me3 status. Thus, our data indicate that SETDB1 restricts activation of nonphysiological TF binding sites which helps to ensure proper maintenance and differentiation of fetal liver HSPCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig Maximilian University Munich, Martinsried 82152, Germany.
- Department of Science and Technological Innovation, University of Piemonte Orientale, Alessandria 15121, Italy.
- Institute for Immunology, Biomedical Center, Faculty of Medicine, Ludwig Maximilian University Munich, Martinsried 82152, Germany.
ORCID-Profile: Maryam Kazerani, Filippo Cernilogar, Gunnar Schotta
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Kazerani, M., Cernilogar, F., Pasquarella, A., Hinterberger, M., Nuber, A., Klein, L., & Schotta, G. (2024). Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2409656121
Vancouver
Kazerani M, Cernilogar F, Pasquarella A, Hinterberger M, Nuber A, Klein L, et al. Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2409656121
BibTeX
@article{Kazerani2024,
author = {Kazerani, Maryam and Cernilogar, Filippo and Pasquarella, Alessandra and Hinterberger, Maria and Nuber, Alexander and Klein, Ludger and Schotta, Gunnar},
title = {Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2409656121}
}
EUVIMED